Texas · 85613

Clotting Factor X Assessment Test, Diluted in Texas

Texas Medicare Avg
$9.36
0% below national avg
National Medicare Avg
$9.37
All states combined
Billed Charge (TX)
$74.45
What providers submit
Est. Commercial (TX)
$21.53
National avg: $20.99
Est. Cash / Self-Pay (TX)
$27.49
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

4.5K
Services in TX
22
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Texas

Provider Medicare Services
Quest Diagnostics Clinical... $9.39 1.1K
Med Fusion, Llc $9.35 887
Clinical Pathology Laboratories,... $9.39 633
Quest Diagnostics Clinical... $9.39 551
Laboratory Corporation Of America $9.39 487
Ayass Lung Clinic, Pllc $9.27 476
Laboratory Corporation Of America $9.39 130
Saadeh, Constantine M.D. $9.22 53
Davey-Ranasinghe, Nicole M.D. $8.88 51
The University Of Texas... $9.39 19
South Texas Clinical Laboratory Ltd $9.39 14

Texas Pricing in Context

In Texas, CPT code 85613 (Clotting Factor X Assessment Test, Diluted) carries an average Medicare payment of $9.36 — 0% below the national benchmark of $9.37. 22 providers across the state submitted claims for this procedure in 2023, performing 4.5K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Texas is $74.45, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in Texas lands near $21.53, with self-pay cash prices typically around $27.49. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Clotting Factor X Assessment Test, Diluted cost in Texas?

The average Medicare payment for Clotting Factor X Assessment Test, Diluted in Texas is $9.36, which is 0% below the national average of $9.37. Providers in TX typically bill $74.45 for this procedure.

What does Clotting Factor X Assessment Test, Diluted cost with insurance in Texas?

With commercial insurance in Texas, Clotting Factor X Assessment Test, Diluted costs an estimated $21.53. Without insurance, the estimated cash price is $27.49. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Clotting Factor X Assessment Test, Diluted in Texas?

22 providers in Texas billed Medicare for Clotting Factor X Assessment Test, Diluted in 2023, performing 4.5K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Clotting Factor X Assessment Test, Diluted cheaper in Texas than the national average?

Yes — Clotting Factor X Assessment Test, Diluted costs 0% below the national average in Texas. The state average Medicare payment is $9.36 compared to $9.37 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial